Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Gilead Sciences' trading volume on March 6th was $693 million, a decrease of 31.10% compared to the previous trading day.
On March 6, 2026, biotech company Gilead Sciences (GILD) had a trading volume of $693 million, ranking 185th among U.S. stocks on that day, a 31.10% decrease from the previous day, with a trading volume of 4.8134 million.
Gilead Sciences (GILD) fell 0.83% on March 6, 2026, closing at $143.93. The stock declined 3.37% over the past 5 trading days, and has decreased 3.37% for the entire month of March. Since the beginning of the year, it has risen 17.26%, and over the past 52 weeks, it has increased by 24.03%.
*If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to now (this also applies to cases where the listing duration is less than 1 month or fewer than 5 trading days).
Gilead Sciences was founded on June 22, 1987, in Delaware. It is a research-based biopharmaceutical company dedicated to discovering, developing, and commercializing innovative drugs to meet unmet medical needs. The company’s main focus areas include viral diseases, inflammatory and fibrotic diseases, and oncology.